Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022

SELL
$2.81 - $5.5 $52,499 - $102,756
-18,683 Closed
0 $0
Q1 2022

May 17, 2022

BUY
$3.42 - $6.37 $63,895 - $119,010
18,683 New
18,683 $78,000
Q4 2021

Feb 17, 2022

SELL
$5.02 - $9.82 $117,297 - $229,454
-23,366 Closed
0 $0
Q3 2021

Nov 12, 2021

BUY
$3.23 - $24.73 $35,061 - $268,444
10,855 Added 86.76%
23,366 $237,000
Q2 2021

Sep 17, 2021

BUY
$2.72 - $3.8 $34,029 - $47,541
12,511 New
12,511 $43,000
Q1 2021

May 19, 2021

SELL
$3.01 - $5.35 $121,167 - $215,364
-40,255 Closed
0 $0
Q4 2020

Feb 24, 2021

BUY
$1.5 - $3.64 $60,382 - $146,528
40,255 New
40,255 $127,000

Others Institutions Holding NURO

# of Institutions
1
Shares Held
320
Call Options Held
0
Put Options Held
0

About NeuroMetrix, Inc.


  • Ticker NURO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 7,757,230
  • Market Cap $28.3M
  • Description
  • NeuroMetrix, Inc., a healthcare company, engages in designing, building, and marketing medical devices that stimulate and analyze nerve response for diagnostic and therapeutic purposes in the United States, Europe, Japan, China, the Middle East, and Mexico. Its primary marketed products include DPNCheck, a nerve conduction test that is used to e...
More about NURO
Track This Portfolio

Track Virtu Financial LLC Portfolio

Follow Virtu Financial LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtu Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtu Financial LLC with notifications on news.